
Color Atlas of Neurology
.pdf
|
|
Index |
|
|
|
|
|
Galactosemia 386 |
Gilles de la Tourette syndrome |
Hartnup disease 306 |
|
Galea aponeurotica 4 |
68 |
Head injury 267 |
|
Gamma-aminobutyric acid |
Glasgow coma scale 378 |
assessment criteria 379 |
|
(GABA) 140, 300 |
Glatiramer acetate 220 |
classification 267 |
|
Gancyclovir 244 |
Glioblastoma 260, 261, 265, |
complications 269, 379 |
|
Gangliocytoma 377 |
377 |
see also Trauma |
|
Ganglioglioma 377 |
Glioma |
Head, zones of 110, 111 |
|
anaplastic 377 |
butterfly 260 |
Headache 182–191, 373 |
|
Ganglioma, parasympathetic |
mixed 377 |
brain tumors and 254, 255 |
|
258 |
Gliomatosis cerebri 260 |
cervical syndrome 188, 189 |
|
Ganglion(a) |
Globus |
upper 188 |
|
basal 24, 42, 210, 211 |
hystericus 102 |
chronic daily 182 |
|
connections 210, 211 |
pallidus 210 |
causes 373 |
|
hemorrhage 176 |
Glomeruli, olfactory 76 |
chronic paroxysmal |
|
Parkinson disease and 210, |
Glomus |
hemicrania (CPH) 186, 190 |
|
211 |
carotid 150 |
cluster 186, 187, 190 |
|
dorsal root 2 |
tumor 377 |
chronic 186, 190 |
|
spinal 2 |
Glutamate 140, 210 |
episodic 186, 190 |
|
trigeminal |
antagonists 212 |
pathogenesis 186 |
|
central connections 94, 95 |
Glutamate decarboxylase 300 |
combination 182 |
|
peripheral connections 94, |
Glycerol 264 |
diagnostic classification 191 |
|
95 |
Glycogen storage disease 340 |
ice-pick 182 |
|
varicella-zoster and 238 |
Goiter 311 |
intracranial hypertension |
|
Ganglioneuropathy 390 |
Gonadotropins 143 |
and 158 |
|
Ganglionitis 238 |
Gordon reflex 40 |
intracranial hypotension and |
|
Gangliosidosis |
Granulomatosis |
160 |
|
GM1 307, 387 |
lymphomatoid 180 |
migraine 184–185, 190, 373 |
|
GM2 307 |
Wegener 180 |
symptoms and signs 184 |
|
Ganser syndrome 138 |
Growth hormones 143, 367 |
aura 184, 185 |
|
Gastrointestinal function 154– |
GH-secreting tumors 258 |
headache phase 184 |
|
155 |
Guillain–Barré syndrome 244, |
prodromal phase 184 |
|
neurological causes of dys- |
326–327, 395 |
resolution phase 184 |
|
function 370 |
clinical spectrum 395 |
nociceptive transmission |
|
Gastroparesis 370 |
diagnosis 326, 396 |
188, 189 |
|
Gaucher disease 306, 307, |
pathogenesis 326 |
posttraumatic 270, 271 |
|
387 |
symptoms and signs 326 |
prophylaxis 190 |
|
Gaze deviation |
treatment 326 |
sinus 186, 187 |
|
contralateral 86 |
Gustatory pathway 78 |
substance-induced 188, 189 |
|
skew 70, 89 |
Gyrus(i) |
acute 188 |
|
Gaze palsy 88 |
angular 124 |
rebound 188 |
|
contralateral 86 |
cingulate 144 |
tension 182, 183 |
|
ipsilateral 86 |
dentate 144 |
chronic 182, 190, 373 |
|
Parkinson disease 208 |
postcentral 12 |
episodic 182, 190 |
|
progressive supranuclear |
precentral 12 |
pathogenesis 182 |
|
palsy 303 |
|
treatment 182, 190 |
|
Genetic predisposition |
H |
trigeminal neuralgia 186, |
|
epilepsy 198 |
187, 190 |
||
Haemophilus influenzae 376 |
|||
Parkinson disease 213 |
idiopathic 186 |
||
spongiform ence- |
chemoprophylaxis 226 |
pathogenesis 186 |
|
phalopathies 252 |
vaccination 226 |
symptomatic 186 |
|
Genotype 288, 289 |
Hair cells 100 |
vascular processes and 166, |
|
Germinoma 258, 377 |
Hallucinations |
182, 183 |
|
Gerstmann syndrome 128 |
olfactory 76 |
subarachnoid hemorrhage |
|
Gerstmann–Sträussler– |
Parkinson disease 208 |
176 |
|
Scheinker syndrome 280 |
Haloperidol 204 |
Hearing 100–101 |
|
Giant axon neuropathy 397 |
Hand grip test 369 |
age-related changes 382 |
|
Gibberish, fluent 124 |
Hangover 188 |
sound perception 100 |
Index
423
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
424
Index
Heart 148–149 |
diagnosis 288 |
pathogenesis 240, 241 |
Heel–knee–shin test 276 |
inheritance 288, 289 |
primary infection 240 |
Heerfordt syndrome 362 |
mutations 288 |
secondary complications |
Helicotrema 100 |
phenotype 288 |
240 |
Hemangioblastoma 256, 257 |
see also specific diseases |
symptoms and signs 240 |
Hemangioma 294 |
Hereditary hemorrhagic tel- |
Huntington 300 |
Hemangiopericytoma 377 |
angiectasia (HHT) 294 |
Huntington disease 66, 300, |
Hematoma 268 |
Hereditary motor–sensory |
301 |
epidural 268, 270 |
neuropathy (HMSN) 332, |
inheritance 300 |
intracerebral 270 |
333, 396 |
anticipation 300 |
intraparenchymal 268 |
type I 332, 333, 396 |
pathogenesis 300 |
posttraumatic 267 |
type II 332, 396 |
symptoms and signs 300 |
subarachnoid 268 |
type III 332, 396 |
Westphal variant 300 |
subdural 268, 270 |
Hereditary neuropathy with |
Hydranencephaly 290, 381 |
chronic 379 |
pressure palsies (HNPP) 332, |
Hydrocephalus 161–163, 290, |
Hemianopsia 82 |
333 |
291, 366, 379, 381 |
heteronymous 82 |
Hering–Breuer reflex 150 |
acute 162, 290 |
homonymous, altitudinal 82 |
Herniation |
brain edema 162–163 |
Hemiballism 66–67 |
intervertebral disk 318, 319, |
chronic 162 |
Hemicrania, chronic paroxys- |
392 |
communicating/malresorp- |
mal (CPH) 186, 190 |
intracranial hypertension |
tive 162 |
Hemineglect 132 |
and 158, 159, 162 |
congenital 290 |
Hemiparesis 47, 122 |
subfalcine 162 |
external 162 |
contralateral 46, 158 |
transtentorial 118, 158 |
non-communicating/ob- |
Hemiplegia 122 |
Herpes labialis 236 |
structive 162, 258, 290 |
alternans 46 |
Herpes simplex 236–237, 376 |
normal-pressure 160, 161, |
Hemodynamic abnormalities |
pathogenesis 236 |
162 |
148, 174 |
symptoms and signs 236 |
subarachnoid hemorrhage |
Hemorrhage 166, 176–179 |
treatment 236 |
and 176 |
intracerebral 166, 167, 176 |
type 1 (HSV-1) 236, 237 |
symptoms and signs 290 |
basal ganglia 176 |
type 2 (HSV-2) 236 |
treatment 290 |
brain stem 176 |
Herpes zoster 180, 238, 239 |
Hydrochlorothiazide 338 |
caudate 176 |
occipitocollaris 238 |
Hydrophobia 246, 247 |
cerebellar 176 |
ophthalmicus 238 |
Hydroxocobalamin 286 |
complications 176 |
oticus 238 |
Hygroma, subdural 379 |
lobar 176 |
sine herpete 238 |
Hyperalgesia 316 |
massive hypertensive 178 |
symptoms and signs 238 |
Hyperammonemia 386 |
pathogenesis 178 |
Hiccups 68 |
Hypercalcemia 310 |
pontine 176 |
Hippocampus 144, 145 |
Hypercapnia 308 |
putaminal 176 |
Histiocytoma, malignant |
Hypereosinophilia syndrome |
thalamic 176 |
fibrous 260 |
344 |
treatment 178 |
History taking 350 |
Hyperesthesia 316 |
intraventricular 166, 176, |
Holmes tremor 357 |
Hyperglycemia 308, 324 |
177, 270 |
Homocystinuria 307 |
hyperosmolar nonketonic |
complications 176 |
Hormones |
308 |
symptoms and signs 176 |
aglandotropic 142 |
Hyperglycinemia, nonketonic |
spinal 282 |
glandotropic 142 |
386 |
subarachnoid 166, 176–177, |
growth 143 |
Hyperhidrosis, Parkinson dis- |
270 |
thyroid 143 |
ease and 208 |
complications 176 |
see also specific hormones |
Hyperkalemia 52, 338, 401 |
pathogenesis 178 |
Horner syndrome 48, 92, 152, |
Hyperkinesia 383 |
symptoms and signs 176 |
318 |
Hypermetria 70 |
treatment 178 |
central 92 |
Hyperprolactinemia 258 |
see also Stroke |
Hospital hopper 138 |
Hypersomnia 114, 116 |
Hepatic encephalopathy 308, |
Human immunodeficiency |
Hypertension 148 |
309, 387 |
virus (HIV) 240–241, 376 |
intracerebral hemorrhage |
Hereditary diseases 288 |
antiretroviral therapy 240 |
and 178 |
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
intracranial 158–160, 224, 268, 290
causes 371 treatment 264, 270
Hyperthermia central 152 malignant 346–347
Hypertrophy, muscular 334, 338, 397
Hyperventilation syndrome 204, 205, 370
Hypervolemia 310
Hypesthesia 106
Hypocalcemia 310 Hypochondriacal disorder 138,
139 Hypogeusia 78
Hypoglycemia 308, 309, 324 acute 308
chronic 308 subacute 308
Hypokalemia 52, 338 Hypokinesia 206 Hypomagnesemia 310 Hypometria 70 Hypomimia 206, 207, 362 Hypoperfusion 174 Hypophonia 206 Hyposmia 76 Hypotension 148, 268
antiparkinsonian medications and 208
idiopathic orthostatic 302 intracranial 160–161
causes 372 Hypothalamic–pituitary regu-
latory axis 367 Hypothalamus 24, 140, 142–
143 functions 142
fluid balance 310 thermoregulation 152
neuroendocrine control 142, 143
pain and 108 Hypothermia 152 Hypothyroidism 311 Hypoventilation 370 Hypovolemia 310 Hypoxia 268
global cerebral 172 hypoxic–ischemic ence-
phalopathy 308, 309
I
Iatrogenic encephalopathy 314, 315, 389
Idiopathic
cerebellar ataxia (IDCA) 276 orthostatic hypotension 302 Parkinson disease 302 torsion dystonia 64 trigeminal neuralgia 186
Immunization see Vaccination Incisura, tentorial 6
Inclusion body myositis 52, 252, 344, 345
Incontinence fecal 216, 370
urinary see Bladder dysfunction
Incus 100
Infantile cerebral palsy see Cerebral palsy
Infarction 172, 174
anterior cerebral artery 168 anterior choroidal artery 168 border zone 168, 172, 173 cerebellar arteries 170 dementia and 298
multi-infarct dementia 298
strategic infarct dementia 298
dorsolateral 170 end zone 172, 173 hemodynamic 172
internal carotid artery 168, 169
border zone 168 territorial 168
lacunar 168, 172 low-flow 172 paramedian 170 pontine 170 spinal
central 282 complete 282
territorial 168, 172, 173, 224 hemorrhagic conversion
172 threshold 174 types of 172
Infections see Central nervous system (CNS); specific
infections
Inflammatory response 224 multiple sclerosis 220 tuberculous meningitis 232
Infundibulum 6
Inheritance 288, 289 monogenic 288 multifactorial 288 polygenic 288 Innervation ratio 44
Insomnia 114
fatal familial 114, 280 psychogenic 114
Inspiration 150
Interoceptors 104 Intervertebral disks 30 Intestine
colon 154 pseudo-obstruction 370 small 154
Intoxication 312, 313 Intracranial pressure (ICP)
158–163
brain tumors and 254 compliance 162 elastance 162
hypertension 158–160, 268, 290
causes 371
clinical features 158–160 treatment 264, 270
hypotension 160–161 causes 372 symptoms 160
pathogenesis 162 Introns 288 Involution 296
Iodine–starch (Minor) test 152 Iris 90
Ischemia 166, 268 cerebral 148 delayed 176 global 172
hypoxic–ischemic encephalopathy 308, 309
threshold 174
transient ischemic attack (TIA) 166
see also Stroke Ischemic penumbra 174 Isocortex 24
Isoniazid 232 Itraconazole 248
J
Jaw jerk reflex 26 JC virus 244
Jefferson’s fracture 380 Jet lag 114
Joints, Charcot 230 Jugum sphenoidale 4
Index
425
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
426
Index
K
Karnofsky scale 26, 378 Kearns–Sayre syndrome (KSS)
403 Keratoconjunctivitis 236 Kernig’s sign 222
King–Denborough syndrome 347
Klippel–Feil syndrome 292, 293
Klumpke–Dejerine palsy 318 Korsakoff syndrome 76, 308,
312
Krabbe disease 307, 332, 387 Kufs disease 307
Kussmaul’s respiration 118
L
Labyrinth 56 Lacrimation, test of 98 Lacunar state 172, 173 Lacunes 172, 298
Lambert–Eaton myasthenic syndrome (LEMS) 50, 52, 342, 343, 406
Lamotrigine 198 Lance–Adams syndrome 308 Language 124–125
aphasia 124, 126–127 model 124
Larynx, voice production 130 Lasègue’s sign 318 Laterocollis 64
Lathyrism 286, 304, 384 Law of Bell and Magendie 30 Leigh disease 306
maternally-inherited (MILS) 403
Lemniscus, trigeminal 94 Lennox–Gastaut syndrome
196, 198
Lens accommodation 90 Leprosy 328, 329 Leptomeninges 6
metastases 262, 263 treatment 265
Leukoaraiosis 298
Leukodystrophy globoid cell 387
metachromatic 306, 307, 332, 333
Leukoencephalitis 234 Levetiracetam 198 Levodopa 208, 212
adverse effects 389
Levomepromazine 264 Lewy bodies 208, 210, 302 Lhermitte’s sign 48, 49, 214 Life expectancy 296
active 296 Lifespan 296
Ligament, denticulate 30 Light reflex 90, 91 Light–near dissociation 92 Limb girdle dystrophy 336,
337, 400
Limbic system 80, 135, 144– 145
functions 144 nerve pathways 144 pain and 108 structure 144, 145 syndromes 368
Lipid metabolism disorders 332, 333
Lissencephaly 381
Listeria 376
Lisuride 212 Lobe
frontal hemorrhage 176 lesions 122
left 122 right 122
occipital, hemorrhage 176 parietal, hemorrhage 176 temporal, hemorrhage 176 Locked-in syndrome 120, 121,
170, 359 LSD abuse 314
Lumbar puncture 2, 407 intracranial hypotension and
160
multiple sclerosis and 218, 219
Lungs 150
Lyme disease 228–229 chronic 228
clinical manifestations 228, 229
diagnosis 228 pathogenesis 228 treatment 228
Lymphadenosis benigna cutis 228
Lymphoma 180, 377, 385 cerebral, primary 260, 261,
265
ocular manifestations 260 non-Hodgkin 260, 261
M
McLeod syndrome 300 Macroadenoma 258 Macrocephaly 290, 381 Macrographia 276 Macrophages 220 Maculae 56
saccular 56 utricular 56
Magnesium balance 310 Magnetic resonance imaging
(MRI) 354
brain tumors 260, 264–265 multiple sclerosis 218, 219 Major histocompatibility com-
plex (MHC) 220
Malaise, brain tumors and 254 Malaria, cerebral 250, 251 Malformations 288, 381
Chiari 292, 293 Dandy–Walker 292
Malignancy see Brain tumors; specific tumors
Malignant hyperthermia 346– 347
Malignant neuroleptic syndrome 208, 347
Malingering 138 Malleus 100 Mannitol 264
Maple syrup urine disease 386 Marcus–Gunn pupils 214 MDMA abuse 314
Mean arterial pressure (MAP) 162, 174
Mechanoreceptors 104, 150 Medulla, adrenal 140 Medulla oblongata 2, 26
caudal 148 lesions 70 rostral 148
syndromes 70, 73, 361 dorsolateral 361 Medulloblastoma 260, 261,
265 Megalencephaly 381
Meige syndrome 64, 362 Melkersson–Rosenthal syn-
drome 362 Melperone 264 Membrane(s) arachnoid 6
spinal 30 basilar 100 tympanic 100 Memory 134–135
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

|
|
Index |
|
|
|
|
|
declarative (explicit) 134, 135 |
viral 234–235 |
Monoparesis 46, 47 |
|
disorders 134, 368 |
herpes zoster 238 |
Monoradiculopathy 316, 318 |
|
Alzheimer disease 297 |
pathogens 234 |
lumbar 318 |
|
head trauma and 269 |
Meningopolyradiculitis 230 |
Monto–Kelli doctrine 162 |
|
Parkinson disease 208 |
Mental retardation 381 |
Motor end plate 2 |
|
episodic 134 |
Mesencephalon 2, 26 |
lesions 50 |
|
examination 134, 353 |
Metachromatic leukodystrophy |
Motor evoked potentials (MEP) |
|
long-term 134 |
306, 307, 332, 333 |
218, 352 |
|
nondeclarative (implicit) |
Metastatic disease 262–263 |
Motor function |
|
134, 135 |
cascade hypothesis 262 |
age-related changes 382 |
|
semantic 134 |
drop metastasis 260, 262 |
Parkinson disease and 210 |
|
short-term 134 |
intracranial 262, 263, 265 |
Motor neuron diseases 304– |
|
Ménière’s disease 58 |
spinal 262, 263, 265 |
305, 384–386 |
|
Meningeosis, neoplastic 262 |
treatment 265 |
lower 50, 304, 385, 386 |
|
Meninges 6–7 |
Methotrexate 220 |
treatment 304 |
|
Meningioma 256, 257, 377 |
Methylprednisolone 220, 238 |
upper 46, 304, 384, 386 |
|
anaplastic 377 |
Metoclopramide 204 |
Motor unit 44 |
|
extracranial 256 |
Mexiletine 338 |
Movements |
|
familial 256 |
Microadenoma 258 |
mass 46 |
|
treatment 264 |
Microaneurysm 179 |
periodic leg 114 |
|
Meningism 222 |
Microangiopathy 172 |
reflex 42 |
|
Meningitis 222, 268 |
Microcephaly 381 |
respiratory 150, 151 |
|
aseptic 234, 236, 242 |
Microglia 220 |
rhythmic 42 |
|
postinfectious 234 |
Micrographia 128, 206, 207 |
spontaneous 50 |
|
postvaccinal 234 |
Micturition 156 |
coma staging 118 |
|
asymptomatic 230 |
Migraine 184–185, 373 |
voluntary 42 |
|
bacterial 180, 226, 376 |
pathogenesis 184 |
see also Dyskinesia(s); |
|
borrelia-related (Lyme) |
symptoms and signs 184 |
Dystonia; Eye movements; |
|
228 |
aura 184, 185 |
Tics; Tremor |
|
tuberculous 232–233 |
headache phase 184 |
Mucor (mucormycosis) 248 |
|
pathogenesis 232 |
prodromal phase 184 |
rhinocerebral 248, 249 |
|
symptoms and signs |
resolution phase 184 |
Multi-infarct dementia 298 |
|
232, 233 |
treatment 190 |
Multifocal motor neuropathy |
|
treatment 232 |
Migration disorder 381 |
(MMN) 328, 329 |
|
Candida and 248 |
Miller–Fisher syndrome 327, |
Multiple organ failure 312 |
|
carcinomatous 262 |
395 |
Multiple sclerosis (MS) 214–221 |
|
chronic 232 |
Mini-Mental Status Examina- |
clinical manifestations 214– |
|
clinical manifestations 222 |
tion 136 |
217, 218, 219 |
|
Lyme disease and 228 |
Mini-syndrome test 136 |
autonomic dysfunction |
|
Mollaret 234 |
Minor test 152 |
216, 217, 371 |
|
neurosyphilis and 230, 231 |
Miosis 90, 382 |
behavioral changes 216, 217 |
|
prophylaxis 226 |
unilateral 92 |
fatigue 214 |
|
viral 234, 376 |
Mitochondrial disorders 288, |
incoordination 216, 217 |
|
pathogens 234 |
307, 398 |
pain 214 |
|
poliovirus 242 |
encephalopathy 281 |
paresis 214 |
|
Meningococcus 376 |
myopathy 52, 398, 403 |
paroxysmal phenomena |
|
vaccination 226 |
Mitoxantrone 220 |
216, 217 |
|
Meningoencephalitis 222 |
Möbius syndrome 362 |
sensory disturbances 214, |
|
arteritis and 226 |
Mollaret meningitis 234 |
215 |
|
bacterial 226, 376 |
Monoclonal gammopathy of |
spasticity 214 |
|
Candida and 248 |
undetermined significance |
visual impairment 214, 215 |
|
cryptococcosis and 248 |
(MGUS) 328 |
course of 214, 216 |
|
neurosyphilis and 230 |
Mononeuritis multiplex 240 |
benign 216 |
|
prophylaxis 226 |
Mononeuropathy 50, 180, 316, |
chronic progressive 214 |
|
treatment 224 |
318, 322–323, 390, 394 |
malignant 216 |
|
guidelines 375 |
multiplex 316, 390 |
relapsing-remitting 214 |
|
tuberculous 232 |
see also Neuropathy |
diagnostic criteria 375 |
Index
427
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
|
Multiple sclerosis (MS) |
|
|
differential diagnosis 216 |
|
|
laboratory tests 218 |
|
|
bladder function 218 |
|
|
cerebrospinal fluid exami- |
|
|
nation 218, 219 |
|
|
evoked potentials 218 |
|
|
neuroimaging 218, 219 |
|
|
pathogenesis 218–221 |
|
|
activation 220, 221 |
|
|
antigen presentation and |
|
|
stimulation 220 |
|
|
demyelination 220 |
|
|
passage through blood– |
|
|
brain barrier 220 |
|
|
scar formation 220 |
|
|
prognosis 216 |
|
|
rehabilitation 220 |
|
|
relapse 214, 220 |
|
|
remission 214 |
|
|
treatment 220 |
|
|
symptomatic therapy 220 |
|
Index |
Multiple system atrophy |
|
(MSA) 276, 302, 303 |
||
|
||
|
bladder dysfunction and 371 |
|
|
Mumps virus 376 |
|
|
Münchhausen syndrome 138 |
|
|
by proxy 138 |
|
|
Muscle phosphorylase defi- |
|
|
ciency 402 |
|
|
Muscle(s) |
|
|
atrophy 49–52, 107, 281, 287, |
|
|
334, 406 |
|
|
peripheral neuropathy and |
|
|
316 |
|
|
poliomyelitis and 242, |
|
|
243 |
|
|
spinal (SMA) 385 |
|
|
spinobulbar 385 |
|
|
cramps 397 |
|
|
detrusor 156 |
|
|
expiratory, auxiliary 150, |
|
|
151 |
|
|
facial, syndromes affecting |
|
|
362 |
|
|
functional disorders 52 |
|
|
hypertrophy 334, 338, 397 |
|
|
levator palpebrae superioris |
|
|
90 |
|
|
pain 52 |
|
|
see also Myalgia |
|
|
respiratory 150 |
|
|
auxiliary 150 |
|
|
segment-indicating 32, 357 |
428spasms 334 stiffness 52, 334
tarsal, superior 90
tone 276
weakness 334, 374, 397, 405 see also Myopathy
Muscular dystrophies 336–337, 398, 400
Becker 336, 337, 400 diagnosis 336
Duchenne 52, 53, 336, 337, 400
Emery–Dreifuss 336, 337 facioscapulohumeral 337,
400
pathogenesis 336, 337 symptoms and signs 336 treatment 336
see also Dystrophy Mutation 288
chromosome 288 gene 288 genome 288 germ-line 288 somatic 288
Myalgia 52, 334, 346, 397 causes 346
toxic 405
Myasthenia gravis 52, 342– 343, 406
aggravating drugs 403 crises 404
diagnosis 342 ancillary tests 404
pathogenesis 342 symptoms and signs 342 treatment 342
Mycobacterium leprae 328
tuberculosis 232, 376 Mycosis, opportunistic sys-
temic 248
see also Fungal infections Mydriasis 90
unilateral 92 Myelin sheath 2
lesions, multiple sclerosis 220
Myelinolysis, central pontine 310, 315
alcoholism and 314 Myelinopathy 316 Myelitis 222, 282
clinical manifestations 222 Lyme disease and 228 treatment 286
viral 282, 376
herpes simplex 236 herpes zoster 238
Myelography 354
Myelomeningoradiculitis, tuberculous 232
Myelopathy 282–287 acute 282–283 cervical 284, 285 chronic 48, 284–284 diagnostic studies 286 hereditary 186
HIV 240
subacute 284–285
subacute combined degeneration (SCD) 286, 287
toxic 286, 287 treatment 286
Myoclonus 66–69, 383 epilepsy with ragged red
fibers (MERRF) 403 essential 68
myoclonic encephalopathies 68
physiological 68 progressive myoclonus
epilepsy with Lafora bodies 307
sleep 68, 114 symptomatic 68
Myokymia 50
Myopathy 50–52, 334–347, 397–405
carnitine deficiency 304, 402 causes 334
centronuclear 402 congenital 52, 340, 341, 398,
402
critical illness (CIM) 347, 379 diagnosis 334, 399 endocrine 347, 398
episodic paralyses 338, 339 hereditary 398 inflammatory 344, 398 malignant hyperthermia
346–347
metabolic 340, 341, 402 mitochondrial 52, 340, 341,
398, 403 myalgia 346
myasthenic syndromes 342– 343
myotonias 338, 339, 401 nemaline 402 paraneoplastic syndromes
347 primary 52
rhabdomyolysis 346 secondary 52 symptoms and signs 334 toxic 398, 405
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

|
|
Index |
|
|
|
|
|
neuromuscular syndromes |
Nerve palsy |
mental 94 |
|
347, 398 |
abducens 86, 87 |
musculocutaneous 35 |
|
see also Muscular dystro- |
facial 96, 98, 99 |
nasociliary 94 |
|
phies |
Lyme disease 228, 229 |
obturator, mononeuropathy |
|
Myopathy, encephalopathy, |
oculomotor 86, 87, 92, 158 |
323 |
|
lactic acidosis and strokelike |
trochlear 86, 87 |
oculomotor, palsy 86, 87, 92, |
|
episodes (MELAS) 403 |
complete 86, 87 |
158, 325 |
|
Myositis 52, 344–345 |
incomplete 86 |
olfactory 2 |
|
diagnosis 344 |
Nerve roots |
ophthalmic 94 |
|
inclusion body 52, 252, 344, |
dorsal 2 |
optic 2, 372 |
|
345 |
spinal 30 |
atrophy 158, 159 |
|
infectious 344 |
root filaments 30 |
peripheral 2 |
|
Lyme disease and 228 |
trauma 272 |
peroneal 37 |
|
ossificans 379 |
avulsion 330 |
mononeuropathy 323, 394 |
|
pathogenesis 344 |
ventral 2 |
phrenic 150 |
|
syndromes 344 |
spinal 30 |
radial 35 |
|
toxoplasmosis and 250 |
Nerve(s) |
mononeuropathy 322, 394 |
|
treatment 344 |
abducens, palsy 86, 87 |
sciatic 37 |
|
viral 52 |
alveolar |
mononeuropathy 394 |
|
Myotomes 32, 33 |
inferior 94 |
spinal 2, 31, 32, 150 |
|
Myotonia 338, 339, 401, 405 |
superior 94 |
supraorbital 94 |
|
action 338 |
auriculotemporal 94 |
supratrochlear 94 |
|
congenital 52, 338, 339 |
axillary 35 |
sural, biopsy 391 |
|
Becker 401 |
mononeuropathy 322, 394 |
thoracic, long, mono- |
|
Thomsen 401 |
buccal 94 |
neuropathy 322, 394 |
|
fluctuans 401 |
cochlear 100 |
tibial 37 |
|
paradoxical 338 |
cranial 2, 6, 28–29, 356 |
mononeuropathy 323, 394 |
|
pathogenesis 338 |
herpes zoster and 238 |
trigeminal 6, 76, 94–95 |
|
percussion 338 |
motor cranial nerve nuclei |
dysfunction 98 |
|
symptoms and signs 338 |
130 |
mesencephalic nucleus 94 |
|
treatment 338 |
nerve pathways 26, 28 |
motor nucleus 94 |
|
Myotonic dystrophy 52, 338, |
see also specific nerves |
principal sensory nucleus |
|
339, 400, 401 |
cutaneous, lateral, of the |
94 |
|
|
thigh 37 |
spinal nucleus 94 |
|
N |
mononeuropathy 323, 394 |
trochlear, palsy 86, 87 |
|
ethmoid |
ulnar 35 |
||
|
|||
Nacrolepsy 114 |
anterior 94 |
mononeuropathy 322, 394 |
|
Nasal cavity 4 |
posterior 94 |
vagus 6, 154 |
|
Natalizumab 220 |
facial 96–99 |
zygomatic 94 |
|
Nausea |
functional systems 96 |
Neural tube defects 292, 293 |
|
brain tumors and 254, 255 |
lesions 98–99 |
Neuralgia 363 |
|
intracranial hypertension |
examination 98 |
postherpetic 238 |
|
and 158, 159 |
palsy 96, 98, 99 |
trigeminal 186, 187, 190 |
|
Near response 90 |
nerve pathways 96 |
idiopathic 186 |
|
Neck stiffness, meningitis and |
femoral 37 |
multiple sclerosis 214 |
|
222, 223 |
mononeuropathy 323, 394 |
pathogenesis 186 |
|
Necrosis 174 |
frontal 94 |
symptomatic 186 |
|
focal 224 |
gluteal, mononeuropathy |
Neuralgic amyotrophy 321, |
|
Needle electromyography 391, |
323 |
328, 329 |
|
399 |
infraorbital 94 |
Neurapraxia 330, 331 |
|
Neocerebellum 54 |
lacrimal 94 |
Neurites, Lewy 210 |
|
Neologisms 124, 126 |
lingual 94 |
Neuritic plaques (NPs) 297 |
|
Nerve injuries 330, 331 |
mandibular 94 |
Neuritis |
|
pathogenesis 330 |
maxillary 94 |
optic, multiple sclerosis 214, |
|
compression 330 |
median 35 |
218 |
|
crushing injuries 330 |
mononeuropathy 322, 394 |
retrobulbar 214 |
|
transection 330 |
meningeal 94 |
toxoplasmosis and 250 |
Index
429
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
430
Index
Neuroacanthocytosis 300, |
spinal |
Neurotuberculosis 232 |
301 |
parasympathetic 140 |
Niemann–Pick disease 306, |
Neuroblastoma 377 |
sympathetic 140 |
307, 387 |
Neuroborreliosis 228–229 |
Neuropathy |
Nightmares 114 |
chronic 228 |
acquired 317, 390 |
Ninhydrin test 152 |
clinical manifestations 228, |
acute motor-axonal (AMAN) |
Nociception 108 |
229 |
395 |
see also Pain |
diagnosis 228 |
acute motor-sensory axonal |
Nodes of Ranvier 2 |
pathogenesis 228 |
(AMSAN) 395 |
Nonneurological disorders |
treatment 228 |
amyloid 333 |
138–139 |
Neurocranium 4 |
diagnosis 316, 391 |
Norepinephrine 140, 382 |
Neurocybernetic prosthesis |
giant axon 397 |
Notch, tentorial 6 |
(NCP) 198 |
hereditary 317, 390 |
Nucleus(i) |
Neurocysticercosis 250, 251 |
peripheral 316–333 |
ambiguus 102, 148 |
Neurodegenerative diseases |
diabetic 324, 325 |
caudate 210 |
296–305 |
hereditary 332–333 |
cochlear |
aging 296 |
metabolic 332, 333 |
anterior 100 |
degenerative changes and |
nonmetabolic 332, 333 |
posterior 100 |
296 |
infectious origin 328 |
cuneatus 104 |
disease and 296 |
inflammatory poly- |
detrusor 156 |
see also specific diseases |
neuropathies 326–329 |
Edinger–Westphal 26, 90 |
Neurofibrillary tangles (NFTs) |
mononeuropathies 318, |
gracilis 104 |
297 |
322–323, 390, 394 |
lentiform 210 |
Neurofibroma 294, 295 |
multifocal motor (MMN) |
motor cranial nerve 130 |
Neurofibromatosis 294, 295 |
328, 329 |
oculomotor 90 |
symptoms and signs 294 |
nerve injuries 330–331 |
Onuf’s 156 |
type 1 (NF1) 294 |
pathogenesis 330 |
Perlia’s 90 |
type 2 (NF2) 258, 294 |
plexopathy 318 |
pulposus 30 |
Neurography 391, 399 |
radicular lesions 318, 320 |
red 24 |
Neurohypophysis 142 |
uremic 324 |
respiratory group |
Neuroimaging 353–354, 391, |
vasculitic 328, 329 |
dorsal 150 |
399 |
small fiber 316 |
ventral 150 |
brain tumors 254, 264–265 |
symptoms and signs 316 |
solitary tract 148 |
multiple sclerosis 218, 219 |
autonomic 316 |
subthalamic 24, 210 |
myasthenia gravis 404 |
motor dysfunction 316 |
tractus solitarius 102 |
Neuroleptics, adverse effects |
sensory dysfunction 316 |
ventral posterolateral (VPL) |
389, 403 |
syndromes 316–317, 390 |
104 |
acute dystonic reaction |
tomaculous 332 |
vestibular 26, 56 |
204 |
Neuropeptides, pain reception |
Nystagmus 70, 86, 88–89 |
malignant neuroleptic syn- |
and 108 |
congenital 88 |
drome 208 |
Neuroprotective therapy 212 |
end-position 88 |
Neuroma, acoustic 258, 259, |
Neurosyphilis 230–231 |
examination 88 |
294 |
clinical manifestations 230, |
gaze-evoked 88, 89, 276, 277 |
Neuromodulators, autonomic |
231 |
gaze-paretic 88 |
nervous system 140–141 |
early meningitis 230, 231 |
jerk 88 |
Neuromuscular junction 2 |
progressive paralysis 230, |
multiple sclerosis 214, 215 |
lesions 50, 347, 398 |
231 |
optokinetic 84, 88 |
paraneoplastic syndromes |
tabes dorsalis 230, 231 |
pathological 88 |
406 |
meningovascular 230 |
physiological 88 |
postpolio syndrome and |
pathogenesis 230 |
positional 70, 88 |
242 |
treatment 230 |
see-saw 70 |
Neuromyotonia 52, 406 |
Neurotmesis 330, 331 |
spontaneous 88, 89 |
Neuronal ceroid lipofuscinosis |
Neurotransmitters |
vestibular |
307 |
autonomic nervous system |
central 88, 89 |
Neuronopathy 316, 390, 406 |
140–141 |
peripheral 88, 89 |
Neurons |
pain reception and 108 |
|
medium spiny-type 210 |
Parkinson disease and 210 |
|
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
O
Obstructive sleep apnea 114 Occlusion 172
basilar artery 170, 171 brachiocephalic trunk 168 carotid artery
common 168 internal 168
cerebellar arteries 170, 171 cerebral artery
middle 168, 169 posterior 170, 171
lenticulostriate artery 168 ophthalmic artery 168 subclavian artery 170
Ocular deviation 70 Oculomotor disturbances
86–88, 276 examination 86
internuclear disturbances 86
peripheral disturbances 86 stroke and 166 supranuclear disturbances
86
Oculomotor function 84–85 Odynophagia 102 Olfaction 76–77
disturbances 76 tests of 76
Olfactory pathway 76 Oligoastrocytoma 256, 377
anaplastic 377 Oligodendroglioma 256, 377
anaplastic 260, 261, 377 One-and-a-half syndrome 86 Onuf’s nucleus 156 Ophthalmoplegia
chronic progressive external (CPEO) 403
internuclear 86, 87, 214 Ophthalmoscopy 80 Opiate abuse 314 Oppenheim reflex 40
Opportunistic infections 240 fungal 248–249
aspergillosis 248, 249 candidosis 248, 249 cryptococcosis 248, 249 mucormycosis 248, 249
Orbit 4, 372 Organ(s)
circumventricular 140 of Corti 100 subfornical 140
Organum vasculosum 140
Orientation evaluation 353 Orthostasis test 369 Osler–Weber–Rendu disease
294 Osmoregulation 310 Ossicles, auditory 100 Overlap syndrome 344 Oxcarbazepine 198 Oxidative stress 212
P
Pachygyria 381
Pachymeninges 6 Pain 108–111
classification of 363 complex regional pain syn-
drome (CRPS) 110 diabetic neuropathy and 324 dysesthesia 106
facial, atypical 373 multiple sclerosis 214 myelopathies 282
nerve pathways 104, 109 neurosyphilis 230 Parkinson disease 208, 209 pathogenesis 108 persistent somatoform pain
disorder 138, 139 processing 108, 109
neurotransmitter/neuropeptide role 108
pseudoradicular 32 radicular 32 reception 108 referred 108, 110, 363
headache 188, 189 sensitization
central 108 peripheral 108
transmission 108 treatment 264, 324 types of 108, 109, 363
central 363 chronic 363 deafferentation 363
neuropathic 108, 363 nociceptive 108, 363 phantom limb 363 psychogenic 363 radicular 363 somatic 108, 363 visceral 108, 110
zones of Head 110, 111 see also Myalgia
Paleocerebellum 54 Pallidotomy 212
Palsy
cerebral, infantile 288–291, 381
causes 288
symptoms and signs 288 treatment 290
Erb 318 Klumpke–Dejerine 318 progressive supranuclear
(PSP) 208, 302, 303 pseudobulbar 362 see also Nerve palsy
Pancoast tumor 262 Panic disorder 202, 203 Papez circuit 144 Papilledema 158, 159, 160
brain tumors and 254, 255 chronic 158, 159 meningitis and 222
Papilloma, choroid plexus 256, 257, 377
Paraganglioma 258 sympathetic 258
Paragrammatism 124, 126 Paralysis
central 46–49
upper motor neuron (UMN) lesions 46
crossed 46, 47, 70 episodic 338, 339, 401
diagnosis 338 pathogenesis 338 prophylaxis 338 symptoms and signs 338 treatment 338
peripheral 50–53 poliomyelitis and 242, 243 progressive, neurosyphilis
and 230, 231
spinal, familial spastic 286, 287
Paramyotonia cold-induced 52 congenita 338, 339, 401
Paraneoplastic syndromes 312, 347, 388
neuromuscular 406 Paraparesis 46
tropical spastic 384 Paraphasia 126
phonemic 124 semantic 124
Paraplegia
familial spastic (FSP) 286, 287, 384
in flexion 214
spinal cord trauma and 274
Index
431
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.

Index
432
Index
Parapraxia 128 |
stereotactic neurosurgical |
Uhthoff’s 214 |
Paraproteinemic poly- |
procedures 212 |
Phenotype 288, 289 |
neuropathy 328, 329, 406 |
symptomatic 212 |
Phenylketonuria 306 |
Parasomnias 114 |
transplant surgery 212 |
Phenytoin 198, 264 |
Parasympathetic nervous |
visual disturbances 208 |
Pheochromocytoma 258 |
system 90, 140, 147, 148, 154 |
Parkinsonism 374, 383 |
Phonation 130 |
Paresis |
atypical 302–303 |
dysphonia 130 |
crossed 47 |
Parosmia 76 |
Phosphofructokinase defi- |
ipsilateral 46 |
Paroxysmal depolarization |
ciency 402 |
Lyme disease and 228, 229 |
shift 198 |
Photoreceptors 104 |
multiple sclerosis 214 |
Pathway(s) |
Physical examination 350–351 |
peripheral 47 |
auditory 100, 101 |
Pia mater 6 |
Paresthesia 106, 316 |
cranial nerves 26–28 |
spinal 30 |
multiple sclerosis 214 |
deglutition 102, 103 |
Pick disease 298, 299 |
spinal artery syndrome 282 |
direct 210 |
Pineal region tumors 258, 259 |
Parinaud syndrome 70, 92, 358 |
facial nerve 96 |
Pineoblastoma 258, 377 |
Parkinson disease 62, 206–213 |
gustatory 78 |
Pineocytoma 258, 377 |
agraphia 128 |
indirect 210 |
“Pisa” syndrome 65, 66 |
autonomic dysfunction 208, |
limbic system 144 |
Pituitary gland 6 |
209 |
olfactory 76 |
anterior lobe 142 |
bladder disorders 208, 371 |
pain 104, 109 |
hypothalamic–pituitary reg- |
blood pressure changes |
pupillomotor 90 |
ulatory axis 367 |
208 |
somatosensory 104 |
posterior lobe 142 |
constipation 208 |
visual 80–81 |
Sheehan’s postpartum |
hyperhidrosis 208 |
Peduncle, cerebellar |
necrosis 258 |
leg edema 208 |
inferior 54 |
stalk 6 |
seborrhea 208 |
lesions 358 |
tumors |
sexual dysfunction 208 |
middle 54 |
adenoma 258, 259, 377 |
sleep disorders 208, 209 |
superior 54 |
metastases 262 |
behavioral changes 206–209 |
Pelizaeus–Merzbacher disease |
treatment 264 |
anxiety 206 |
387 |
Plasmodium falciparum (cere- |
dementia 208 |
Penicillin 230 |
bral malaria) 250, 251 |
depression 206 |
Peregrinating patient 138 |
Platybasia 292, 293 |
hallucinations 208 |
Pergolide 212 |
Plexopathy 50, 318, 321 |
cardinal manifestations 206, |
Pericranium 4, 6 |
Plexus(es) 32–36 |
207 |
Perineurium 2, 30 |
brachial 32, 34, 318 |
akinesia 206 |
Peripheral nervous system |
infraclavicular region 318 |
bradykinesia 206 |
(PNS) 2, 3 |
Pancoast tumor 262 |
hypokinesia 206 |
Peristalsis 154 |
plexopathy 318, 321, 393 |
postural instability 206, |
Peritonitis 226 |
supraclavicular region 318 |
207 |
Perlia’s nucleus 90 |
trauma 272, 330 |
rigidity 206, 207 |
Perphenazine 204 |
cervical 32, 35 |
tremor 206, 207 |
Perseveration 126 |
cervicobrachial 34 |
dystonia 208, 209 |
Persistent somatoform pain |
choroid 6, 8 |
genetics of 213 |
disorder 138, 139 |
carcinoma 377 |
idiopathic 302 |
Persistent vegetative state 120, |
papilloma 256, 257, 377 |
pathogenesis 210–211 |
121 |
coccygeal 32 |
basal ganglia 210, 211 |
Personality 122 |
ganglionic, submucous 154 |
connections 210, 211 |
Phakomatoses 294–295, 381 |
lumbar 32, 36 |
motor function 210 |
Phencyclidine (PCP) abuse 314 |
lumbosacral 36 |
neurotransmitters 210 |
Phenobarbital 198 |
plexopathy 318, 321, 393 |
sensory manifestations 208 |
Phenomenon |
myenteric 154 |
dysesthesias 208 |
black-curtain 168 |
pterygoid 20 |
pain 208, 209 |
doll’s-eye 26, 302, 303 |
sacral 32 |
treatment 212–213 |
coma and 118 |
lesions 318 |
deep brain stimulation 212 |
extinction 132 |
vertebral venous |
neuroprotective 212 |
rebound 276, 277 |
external 22 |
|
|
internal 22 |
Rohkamm, Color Atlas of Neurology © 2004 Thieme
All rights reserved. Usage subject to terms and conditions of license.